NCT00417326

Controlled Study of ONO-5046Na in Patients With Acute Respiratory Failure Associated With Community-Acquired Pneumonia

ONO-5046Na Phase II Study - A Pilot Study for Patients With Acute Respiratory Failure

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 174 (actual)
• Sponsor: Ono Pharmaceutical Co., Ltd. · Industry
• Sex: All
• Age: 20 Years – 79 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the safety and efficacy of ONO-5046Na in patients with acute respiratory failure associated with community-acquired pneumonia

Conditions

• Community-acquired Pneumonia

Interventions

Type	Name	Description
DRUG	ONO-5046Na	twenty four hour infusion at 0 mg/kg/hr for 14 days
DRUG	ONO-5046Na	twenty four hour intravenous infusion at 0.2 mg/kg/hr for 14 days

Timeline

• Start date: 2006-12-01
• Primary completion: 2009-08-01
• First posted: 2007-01-01
• Last updated: 2012-06-13

Locations

9 sites across 1 country: Japan